EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revisiting mRNA capping in Mononegavirales : a promising, yet underexplored antiviral target

Khadijah Khan iD, Mohammad Ejaz Adil, Monika Antil, Dilip Kumar iD

Journal of Virology · 2026

DOI: 10.1128/jvi.01025-26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Virology, 2026. Verfasst von Khadijah Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Trivedi School of Biosciences, Ashoka University, Sonipat, Haryana, India. Hauptthemen laut MEDLINE: RNA Caps, Mononegavirales, RNA, Viral, Antiviral Agents. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA capping is a co-transcriptional, nuclear process in eukaryotes that adds a cap onto the 5' end of RNA to confer stability, efficient translation, and nuclear export. Viruses have evolved diverse strategies by mimicking or subverting host pathways to install an mRNA cap for efficient gene expression and evasion of the host innate immune response. The conventional mRNA capping pathway, employed by many RNA and DNA viruses, is mediated by dedicated RNA 5′-triphosphatase, guanylyltransferase, and methyltransferase enzymes. In contrast, many RNA viruses utilize unconventional capping mechanisms that diverge from the canonical pathway, offering unique opportunities to develop virus family-specific antiviral therapeutics. Among negative-sense RNA viruses, members of the order Mononegavirales harbor a unique capping domain, polyribonucleotidyltransferase (PRNTase), embedded within the viral RdRp large (L) protein. Unlike the conventional guanylyltransferase-mediated mechanism, PRNTase catalyzes mRNA capping through the formation of a covalent L-pRNA intermediate rather than the canonical GMP-enzyme intermediate. The HR motif in PRNTase, involved in covalent linking to mRNA, is highly conserved in non-segmented negative-strand RNA viruses. This review focuses on structural and functional insights into Mononegavirales capping, highlighting the conserved motifs and domain architecture that make it a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA CapsMononegaviralesRNA, ViralAntiviral AgentsRNA, MessengerHumansViral ProteinsNucleotidyltransferasesAcid Anhydride Hydrolases

Stichwörter der Autor:innen

MononegaviralesPRNTaseRNA cappingantiviral targetparamyxovirus

Substanzen

RNA CapsRNA, ViralAntiviral AgentsRNA, MessengerViral ProteinsguanylyltransferaseRNA triphosphataseNucleotidyltransferasesAcid Anhydride Hydrolases

Autor:innen und Institutionen

  • Trivedi School of Biosciences, Ashoka University, Sonipat, Haryana, India.
  • Department of Biology, Ashoka University, Sonipat, Haryana, India.

ORCID-Profile: Khadijah Khan, Dilip Kumar

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Khan, K., Adil, M. E., Antil, M., & Kumar, D. (2026). Revisiting mRNA capping in Mononegavirales : a promising, yet underexplored antiviral target. Journal of Virology. https://doi.org/10.1128/jvi.01025-26

Vancouver

Khan K, Adil ME, Antil M, Kumar D. Revisiting mRNA capping in Mononegavirales : a promising, yet underexplored antiviral target. Journal of Virology. 2026. doi:10.1128/jvi.01025-26

BibTeX
@article{Khan2026,
  author = {Khan, Khadijah and Adil, Mohammad Ejaz and Antil, Monika and Kumar, Dilip},
  title = {Revisiting mRNA capping in Mononegavirales : a promising, yet underexplored antiviral target},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01025-26}
}
Kostenlos starten →